Selecta Biosciences Inc reports results for the quarter ended in March - Earnings Summary

Cartesian Therapeutics

05/05/2022 19:43

* Selecta Biosciences Inc  SELB.OQ  reported quarterly
adjusted
earnings of 8 cents​​ per share for the quarter ended in March.
The mean expectation of six analysts for the quarter was for a
loss of 11 cents per share.
    * Revenue rose 207.7% to $34.00 million from a year ago; 
analysts
expected $13.12 million. 
    * Selecta Biosciences Inc's reported EPS for the quarter was
8
cents​.
    * The mean earnings estimate of analysts had risen by
about 3% in
the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Selecta Biosciences Inc shares had fallen by 34.9% this
quarter and lost 75.4% so far this year.
    * The company reported quarterly net income of $28.78
million.
    * Wall Street's median 12-month price target for Selecta
Biosciences Inc is $8.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 5 at 06:43 p.m.  ​All
figures in US dollars unless otherwise stated